PEAK6 Group’s Meridian Bioscience Inc VIVO Stock Holding History

PEAK6 Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$17K	Sell	1,100 -39,500	-97%	-$589K	﹤0.01%	4095
2018 Q1	$577K	Buy	40,600 +30,800	+314%	+$456K	﹤0.01%	2448
2017 Q4	$137K	Buy	+9,800	New	+$143K	﹤0.01%	3381
2016 Q3	–	Sell	-36,200	Closed	-$706K	–	4850
2016 Q2	$706K	Buy	36,200 +16,200	+81%	+$318K	0.01%	2087
2016 Q1	$412K	Buy	+20,000	New	+$394K	﹤0.01%	2457
2015 Q4	–	Sell	-20,800	Closed	-$356K	–	5441
2015 Q3	$356K	Buy	20,800 +1,800	+9%	+$32.9K	﹤0.01%	3208
2015 Q2	$354K	Buy	19,000 +8,100	+74%	+$150K	﹤0.01%	3139
2015 Q1	$208K	Buy	+10,900	New	+$202K	﹤0.01%	3411

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PEAK6 Group's VIVO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Meridian Bioscience Inc (VIVO) in Q2 2018: 10,759 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #3438 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in VIVO as recently as Q2 2016.

PEAK6 Group first reported a position in VIVO in Q2 2015 and has held it in 4 quarters since. The position peaked at $877K in Q2 2015. 177 funds tracked by Wall St. Rank hold VIVO as of Q2 2018.

PEAK6 Group held 10,759 shares of Meridian Bioscience Inc worth $171K as of Q2 2018.
Meridian Bioscience Inc was a new PEAK6 Group position in Q2 2018.
Meridian Bioscience Inc made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3438 holding.
PEAK6 Group first reported a position in Meridian Bioscience Inc in Q2 2015 and has held it in 4 quarters since.
PEAK6 Group's Meridian Bioscience Inc position peaked at $877K in Q2 2015.
177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.